Skip to content

Effect of manual therapy of the vagus nerve on pain and thoracic expansion in patients with neck pain

Effect of manual therapy of the vagus nerve on pain and thoracic expansion in patients with chronic non-specific neck pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9d8ryw
Enrollment
Unknown
Registered
2019-04-22
Start date
2019-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Interventions

Experimental group: 20 women with chronic neck pain will receive myofascial release manual therapy at the base of the skull, neck, chest and abdomen for 20 minutes followed by deep inspiratory and exp
Other
E02.190.599
E02.190.525.186

Sponsors

Centro Universitário União das Américas - UNIAMÉRICA
Lead Sponsor
Centro Universitário União das Américas - UNIAMÉRICA
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged between 18and 65 years; body mass index (BMI) <30 kg / m², with neck pain for a period equal or greater than 3 months; a Portuguese-Brazilian version of the Neck Disability Index (NDI) score of 5 or higher and a Numeric Rating Scale (NRS) score of 3 or higher at rest or during active neck movement. The participant must be willing to participate in the study and sign the Informed Consent Term.

Exclusion criteria

Exclusion criteria: Participants are excluded if they had: bone diseases; bone fracture; history of tumor or cancer; cervical whiplash injury; history of neck trauma; previous spine surgery; have undergone physiotherapeutic or medical treatment for neck pain in the last 3 months prior to the study; using analgesic, anti-inflammatory and muscle relaxant medications during the week prior to the study; use of medications that could alter cardiac autonomic activity, such as (propranolol and atropine); systemic diseases; diagnosed fibromyalgia; diagnosed cardiovascular disease; orofacial pain; pregnancy; cervical radiculopathy; smoking; ethyl alcohol; diagnosed respiratory disease; diagnosed neuromuscular disease; and inability to perform the tests and answer the questionnaires.

Design outcomes

Primary

MeasureTime frame
It is expected to find a decrease in pain perception, verified by the visual analogue scale, based on the statistical analysis of pre and post-intervention measurements.;It is expected to find an increase in the pressure pain threshold, verified by algometry, based on the statistical analysis of pre and post-intervention measurements.;It is expected to find an increase in the measurements of thoracic expansion, verified by cirtometry, based on the statistical analysis of pre and post-intervention measurements.

Secondary

MeasureTime frame
An increase in heart rate variability, verified by the heart monitor, is expected from the statistical analysis of pre and post-intervention measurements.

Countries

Brazil

Contacts

Public ContactDavid Lam

Centro Universitário União das Américas - UNIAMÉRICA

dlam1984@hotmail.com5545999777382

Outcome results

None listed

Source: REBEC (via WHO ICTRP)